Schonfeld Strategic Advisors LLC Charles River Laboratories International, Inc. Transaction History

Schonfeld Strategic Advisors LLC

$14.6 Billion
Q2 2024

A detailed history of Schonfeld Strategic Advisors LLC transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Schonfeld Strategic Advisors LLC holds 2,142 shares of CRL stock, worth $398,154. This represents 0.0% of its overall portfolio holdings.

Number of Shares

2,142

Previous 63,545 96.63%

Holding current value

$398,154

Previous $17.2 Million 97.43%

% of portfolio

0.0%

Previous 0.12%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$206.39 - $268.73 $12.7 Million - $16.5 Million	-61,403 Reduced 96.63%	2,142 $442,000
Q1 2024 May 15, 2024	BUY	$203.52 - $273.43 $12.9 Million - $17.4 Million	63,545 New	63,545 $17.2 Million
Q3 2023 Nov 14, 2023	BUY	$194.44 - $217.61 $1.61 Million - $1.8 Million	8,285 Added 222.77%	12,004 $2.35 Million
Q2 2023 Aug 14, 2023	BUY	$183.71 - $210.25 $683,217 - $781,919	3,719 New	3,719 $781,000
Q1 2022 May 16, 2022	SELL	$255.51 - $362.11 $327,819 - $464,587	-1,283 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$351.38 - $448.68 $450,820 - $575,656	1,283 New	1,283 $483,000
Q3 2021 Nov 16, 2021	SELL	$372.64 - $458.3 $324,569 - $399,179	-871 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$294.17 - $371.65 $1.54 Million - $1.94 Million	-5,223 Reduced 85.71%	871 $323,000
Q1 2021 May 17, 2021	BUY	$249.67 - $299.48 $591,218 - $709,168	2,368 Added 63.55%	6,094 $1.77 Million
Q4 2020 Feb 16, 2021	SELL	$222.0 - $252.62 $782,550 - $890,485	-3,525 Reduced 48.61%	3,726 $931,000
Q3 2020 Nov 16, 2020	BUY	$175.56 - $226.45 $1.27 Million - $1.64 Million	7,251 New	7,251 $2,000
Q2 2020 Aug 14, 2020	SELL	$118.84 - $189.72 $953,334 - $1.52 Million	-8,022 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$98.9 - $178.34 $629,993 - $1.14 Million	6,370 Added 385.59%	8,022 $1.01 Million
Q4 2019 Feb 14, 2020	SELL	$126.05 - $152.76 $485,040 - $587,820	-3,848 Reduced 69.96%	1,652 $252,000
Q3 2019 Nov 14, 2019	SELL	$125.07 - $143.67 $775,434 - $890,753	-6,200 Reduced 52.99%	5,500 $728,000
Q2 2019 Aug 14, 2019	SELL	$123.4 - $148.55 $3.35 Million - $4.03 Million	-27,108 Reduced 69.85%	11,700 $1.66 Million
Q1 2019 May 15, 2019	BUY	$104.82 - $146.73 $635,733 - $889,917	6,065 Added 18.52%	38,808 $5.64 Million
Q4 2018 Feb 14, 2019	BUY	$105.09 - $137.23 $1.21 Million - $1.58 Million	11,491 Added 54.07%	32,743 $3.71 Million
Q3 2018 Nov 14, 2018	SELL	$112.11 - $134.54 $980,738 - $1.18 Million	-8,748 Reduced 29.16%	21,252 $2.86 Million
Q2 2018 Aug 14, 2018	BUY	$102.37 - $117.25 $511,850 - $586,250	5,000 Added 20.0%	30,000 $3.37 Million
Q1 2018 May 15, 2018	SELL	$98.19 - $115.2 $2.47 Million - $2.89 Million	-25,125 Reduced 50.12%	25,000 $2.67 Million
Q4 2017 Feb 14, 2018	BUY	$100.43 - $118.09 $12,553 - $14,761	125 Added 0.25%	50,125 $5.49 Million
Q3 2017 Nov 14, 2017	BUY	$96.72 - $109.26 $4.84 Million - $5.46 Million	50,000	50,000 $5.4 Million

Others Institutions Holding CRL

# of Institutions

720

Shares Held

52.3M

Call Options Held

233K

Put Options Held

236K

View Full List

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.

Ticker CRL
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 50,863,300
Market Cap $9.45B
Description
Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...

More about CRL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Schonfeld Strategic Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Schonfeld Strategic Advisors LLC with notifications on news.

Account

Schonfeld Strategic Advisors LLC Charles River Laboratories International, Inc. Transaction History